Interview: MedTech Europe's Bernasconi Says Reg Complexities Warrant Longer Transition Period
Executive Summary
The near final texts of the Medical Devices and IVD Regulation texts are available, and the sector is champing at the bit to prepare for its new regulatory future. Yet there are many hurdles to cope with, especially because of challenges with notified bodies, and the current unpredictable regulatory environment. MedTech Europe’s Serge Bernasconi spoke to Medtech Insight about his views on why now is a particularly challenging time for companies operating in Europe.
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.